MATTHEW JAMES to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications MATTHEW JAMES has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.651
-
Nurse Practitioner Care Compared with Primary Care or Nephrologist Care in Early CKD. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1533-1544.
Score: 0.203
-
Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study. J Surg Res. 2021 07; 263:34-43.
Score: 0.170
-
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury. JAMA Intern Med. 2018 12 01; 178(12):1681-1690.
Score: 0.146
-
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol. 2014 Apr 02; 15:53.
Score: 0.105
-
Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome. Clin J Am Soc Nephrol. 2014 Nov 07; 9(11):1840-8.
Score: 0.027